|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Petry KU: HPV and cervical cancer. Scand J
Clin Lab Invest Suppl. 244:59–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pu X, Wang L, Chang JY, Hildebrandt MA, Ye
Y, Lu C, Skinner HD, Niu N, Jenkins GD, Komaki R, et al:
Inflammation-related genetic variants predict toxicity following
definitive radiotherapy for lung cancer. Clin Pharmacol Ther.
96:609–615. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pinato DJ: Cancer-related inflammation: An
emerging prognostic domain in metastatic castration-resistant
prostate carcinoma. Cancer. 120:3272–3274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang WJ, Du Y, Zhao X, Ma LY and Cao GW:
Inflammation-related factors predicting prognosis of gastric
cancer. World J Gastroenterol. 20:4586–4596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Jia H, Xie L, Wang X, He H, Lin Y
and Hu L: Correlation of inhibitor of differentiation 1 expression
to tumor progression, poor differentiation and aggressive behaviors
in cervical carcinoma. Gynecol Oncol. 114:89–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Jia H, Xie L, Wang X, Wang X, He H,
Lin Y and Hu L: Association of constitutive nuclear factor-kappaB
activation with aggressive aspects and poor prognosis in cervical
cancer. Int J Gynecol Cancer. 19:1421–1426. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moss SF and Blaser MJ: Mechanisms of
disease: Inflammation and the origins of cancer. Nat Clin Pract
Oncol. 2:90–97. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Serralbo O and Marcelle C: Migrating cells
mediate long-range WNT signaling. Development. 141:2057–2063. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nathan JA, Sengupta S, Wood SA, Admon A,
Markson G, Sanderson C and Lehner PJ: The ubiquitin E3 ligase
MARCH7 is differentially regulated by the deubiquitylating enzymes
USP7 and USP9X. Traffic. 9:1130–1145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu J, Meng Y, Yu T, Hu L and Mao M:
Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growth.
Oncotarget. 6:12174–12187. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin Q, Huang F, Wang X, Zhu H, Xian Y, Li
J, Zhang S and Ni Q: High Eg5 expression predicts poor prognosis in
breast cancer. Oncotarget. 8:62208–62216. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He HJ, Zhu TN, Xie Y, Fan J, Kole S,
Saxena S and Bernier M: Pyrrolidine dithiocarbamate inhibits
interleukin-6 signaling through impaired STAT3 activation and
association with transcriptional coactivators in hepatocytes. J
Biol Chem. 281:31369–31379. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salic A and Mitchison TJ: A chemical
method for fast and sensitive detection of DNA synthesis in vivo.
Proc Natl Acad Sci USA. 105:2415–2420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu J, Meng Y, Zhang Z, Yan Q, Jiang X, Lv
Z and Hu L: MARCH5 RNA promotes autophagy, migration, and invasion
of ovarian cancer cells. Autophagy. 13:333–344. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang Z, Chen X, Yu B, He J and Chen D:
MicroRNA-27a promotes myoblast proliferation by targeting
myostatin. Biochem Biophys Res Commun. 423:265–269. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng Y, Wang W, Ma J, Wang X, Guo M and Li
W: Knockdown of ZNF268, which is transcriptionally downregulated by
GATA-1, promotes proliferation of K562 cells. PLoS One.
7:e295182012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu H, Fu S, Chen Q, Gu M, Zhou J, Liu C,
Chen Y and Wang Z: The function of oxytocin: A potential biomarker
for prostate cancer diagnosis and promoter of prostate cancer.
Oncotarget. 8:31215–31226. 2017.PubMed/NCBI
|
|
20
|
JingSong H, Hong G, Yang J, Duo Z, Li F,
WeiCai C, XueYing L, YouSheng M, YiWen O, Yue P and Zou C:
siRNA-mediated suppression of collagen type iv alpha 2 (COL4A2)
mRNA inhibits triple-negative breast cancer cell proliferation and
migration. Oncotarget. 8:2585–2593. 2017.PubMed/NCBI
|
|
21
|
Ghoochani A, Hatipoglu Majernik G, Sehm T,
Wach S, Buchfelder M, Taubert H, Eyupoglu IY and Savaskan N:
Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis
induction and stalls brain tumor angiogenesis. Oncotarget.
7:38306–38318. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feldner JC and Brandt BH: Cancer cell
motility-on the road from c-erbB-2 receptor steered signaling to
actin reorganization. Exp Cell Res. 272:93–108. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abe K, Rossman KL, Liu B, Ritola KD,
Chiang D, Campbell SL, Burridge K and Der CJ: Vav2 is an activator
of Cdc42, Rac1, and RhoA. J Biol Chem. 275:10141–10149. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Citterio C, Menacho-Márquez M,
García-Escudero R, Larive RM, Barreiro O, Sánchez-Madrid F, Paramio
JM and Bustelo XR: The rho exchange factors vav2 and vav3 control a
lung metastasis-specific transcriptional program in breast cancer
cells. Sci Signal. 5:ra712012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahn J, Truesdell P, Meens J, Kadish C,
Yang X, Boag AH and Craig AW: Fer protein-tyrosine kinase promotes
lung adenocarcinoma cell invasion and tumor metastasis. Mol Cancer
Res. 11:952–963. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Havel LS, Kline ER, Salgueiro AM and
Marcus AI: Vimentin regulates lung cancer cell adhesion through a
VAV2-Rac1 pathway to control focal adhesion kinase activity.
Oncogene. 34:1979–1990. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Menacho-Márquez M, García-Escudero R,
Ojeda V, Abad A, Delgado P, Costa C, Ruiz S, Alarcón B, Paramio JM
and Bustelo XR: The Rho exchange factors Vav2 and Vav3 favor skin
tumor initiation and promotion by engaging extracellular signaling
loops. PLoS Biol. 11:e10016152013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li HP, Huang HY, Lai YR, Huang JX, Chang
KP, Hsueh C and Chang YS: Silencing of miRNA-148a by
hypermethylation activates the integrin-mediated signaling pathway
in nasopharyngeal carcinoma. Oncotarget. 5:7610–7624. 2014.
View Article : Google Scholar : PubMed/NCBI
|
